$RNAC
Cartesian Therapeutics, Inc.

2024 Q3 Form 10-Q Financial Statement

#000145368724000102 Filed on August 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $387.0K $33.45M
YoY Change -94.09% 537.17%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.562M $7.027M
YoY Change -0.79% 15.1%
% of Gross Profit
Research & Development $11.40M $12.66M
YoY Change -12.32% -28.8%
% of Gross Profit
Depreciation & Amortization $300.0K $200.0K
YoY Change 200.0% 0.0%
% of Gross Profit
Operating Expenses $17.96M $19.69M
YoY Change -8.43% -17.58%
Operating Profit -$17.58M $13.76M
YoY Change 34.52% -173.81%
Interest Expense $2.573M $1.195M
YoY Change 102.12% 58.91%
% of Operating Profit 8.69%
Other Income/Expense, Net $250.0K $292.0K
YoY Change -1.19% 19.18%
Pretax Income -$24.18M $13.84M
YoY Change 168.64% -221.51%
Income Tax
% Of Pretax Income
Net Earnings -$24.18M $13.84M
YoY Change 168.64% -221.51%
Net Earnings / Revenue -6248.84% 41.37%
Basic Earnings Per Share -$1.13 $0.58
Diluted Earnings Per Share -$1.13 $0.54
COMMON SHARES
Basic Shares Outstanding 21.38M shares 17.80M shares
Diluted Shares Outstanding 21.47M shares 17.79M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $219.2M $87.23M
YoY Change 175.36% -22.14%
Cash & Equivalents $219.2M $87.23M
Short-Term Investments
Other Short-Term Assets $4.129M $2.044M
YoY Change 18.21% -52.0%
Inventory
Prepaid Expenses
Receivables $4.829M $32.04M
Other Receivables $980.0K $3.472M
Total Short-Term Assets $229.1M $124.8M
YoY Change 154.97% 1.68%
LONG-TERM ASSETS
Property, Plant & Equipment $10.23M $6.672M
YoY Change 322.35% 157.31%
Goodwill $48.16M $48.16M
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.000M $2.000M
YoY Change 0.0% 0.0%
Other Assets $1.669M $1.669M
YoY Change 18.79% 18.12%
Total Long-Term Assets $226.2M $223.0M
YoY Change 1299.2% 1228.62%
TOTAL ASSETS
Total Short-Term Assets $229.1M $124.8M
Total Long-Term Assets $226.2M $223.0M
Total Assets $455.3M $347.7M
YoY Change 329.41% 149.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $517.0K $2.862M
YoY Change 37.87% 971.91%
Accrued Expenses $9.363M $10.62M
YoY Change -31.34% -17.73%
Deferred Revenue $0.00 $0.00
YoY Change -100.0% -100.0%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $21.41M $26.12M
YoY Change 7.35% -11.07%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $417.3M $407.2M
YoY Change 1519.6% 1217.72%
Total Long-Term Liabilities $417.3M $407.2M
YoY Change 1519.6% 811.21%
TOTAL LIABILITIES
Total Short-Term Liabilities $21.41M $26.12M
Total Long-Term Liabilities $417.3M $407.2M
Total Liabilities $454.6M $449.2M
YoY Change 894.56% 506.55%
SHAREHOLDERS EQUITY
Retained Earnings -$681.8M -$657.6M
YoY Change 56.02% 53.65%
Common Stock $2.000K $2.000K
YoY Change -86.67% -86.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $752.0K -$101.5M
YoY Change
Total Liabilities & Shareholders Equity $455.3M $347.7M
YoY Change 329.41% 149.26%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$24.18M $13.84M
YoY Change 168.64% -221.51%
Depreciation, Depletion And Amortization $300.0K $200.0K
YoY Change 200.0% 0.0%
Cash From Operating Activities $13.69M -$14.45M
YoY Change -248.57% 45.99%
INVESTING ACTIVITIES
Capital Expenditures $6.199M $1.587M
YoY Change 13125.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$6.199M -$1.587M
YoY Change 13125.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 124.5M 120.0K
YoY Change -602.21% -104.64%
NET CHANGE
Cash From Operating Activities 13.69M -14.45M
Cash From Investing Activities -6.199M -1.587M
Cash From Financing Activities 124.5M 120.0K
Net Change In Cash 132.0M -15.91M
YoY Change -488.15% 27.38%
FREE CASH FLOW
Cash From Operating Activities $13.69M -$14.45M
Capital Expenditures $6.199M $1.587M
Free Cash Flow $7.492M -$16.03M
YoY Change -181.3% 61.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36406000 usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
9819544.247 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
9451625 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17816238 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17816238 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
2000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
560766000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
179062000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-657635000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-614647000 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4591000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4600000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-101458000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-440184000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
347738000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
305050000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33271000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5249000 usd
CY2024Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0333
CY2024Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0333
us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Net Derivative Asset Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2024#GainLossOnDerivativeInstrumentsNetPretax
CY2024Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0333
CY2024Q2 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2024Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5397597 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5397597 shares
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39111000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11187000 usd
CY2024Q2 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
174000 usd
CY2023Q2 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
0 usd
us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
174000 usd
us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
0 usd
CY2024Q2 us-gaap Revenues
Revenues
33445000 usd
CY2023Q2 us-gaap Revenues
Revenues
5249000 usd
us-gaap Revenues
Revenues
39285000 usd
us-gaap Revenues
Revenues
11187000 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12661000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17782000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22399000 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7027000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6105000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16477000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11800000 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
19688000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
23887000 usd
us-gaap Operating Expenses
OperatingExpenses
38876000 usd
us-gaap Operating Expenses
OperatingExpenses
48206000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
13757000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-18638000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
409000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-37019000 usd
CY2024Q2 us-gaap Investment Income Net
InvestmentIncomeNet
1195000 usd
CY2023Q2 us-gaap Investment Income Net
InvestmentIncomeNet
1394000 usd
us-gaap Investment Income Net
InvestmentIncomeNet
2359000 usd
us-gaap Investment Income Net
InvestmentIncomeNet
2725000 usd
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
23000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
42000 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
0 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
752000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
0 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1560000 usd
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
3908000 usd
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6341000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2866000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2262000 usd
CY2024Q2 rnac Fair Value Adjustment Of Contingent Value Right Liability
FairValueAdjustmentOfContingentValueRightLiability
-2500000 usd
CY2023Q2 rnac Fair Value Adjustment Of Contingent Value Right Liability
FairValueAdjustmentOfContingentValueRightLiability
0 usd
rnac Fair Value Adjustment Of Contingent Value Right Liability
FairValueAdjustmentOfContingentValueRightLiability
36800000 usd
rnac Fair Value Adjustment Of Contingent Value Right Liability
FairValueAdjustmentOfContingentValueRightLiability
0 usd
CY2024Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0 usd
CY2023Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-6890000 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
292000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
245000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
800000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
500000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
13836000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-11387000 usd
us-gaap Net Income Loss
NetIncomeLoss
-42988000 usd
us-gaap Net Income Loss
NetIncomeLoss
-33050000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
14000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-27000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
9000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-49000 usd
CY2024Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
11000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13850000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11414000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-42979000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-33088000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
13836000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-11387000 usd
us-gaap Net Income Loss
NetIncomeLoss
-42988000 usd
us-gaap Net Income Loss
NetIncomeLoss
-33050000 usd
CY2024Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
4208000 usd
CY2024Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
4208000 usd
CY2023Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
0 usd
CY2023Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
0 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
0 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
9628000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
9628000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11387000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-11387000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-42988000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-42988000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-33050000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-33050000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.88
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.46
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.88
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.46
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16723479 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11068749 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5113213 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17791143 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5114747 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11068749 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5113213 shares
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
435120.513 shares
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
296851000 usd
CY2023Q4 rnac Temporary Equity Options Carrying Amount Attributable To Parent
TemporaryEquityOptionsCarryingAmountAttributableToParent
3703000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-440184000 usd
CY2024Q1 rnac Temporary Equity Stock Issued During Period Shares
TemporaryEquityStockIssuedDuringPeriodShares
99140.326 shares
CY2024Q1 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
75197000 usd
CY2024Q1 rnac Temporary Equity Transfer Of Preferred Stock To Permanent Equity Shares
TemporaryEquityTransferOfPreferredStockToPermanentEquityShares
534260.839 shares
CY2024Q1 rnac Temporary Equity Transfer Of Preferred Stock To Permanent Equity
TemporaryEquityTransferOfPreferredStockToPermanentEquity
372048000 usd
CY2024Q1 rnac Temporary Equity Options Transfer Of Preferred Stock To Permanent Equity
TemporaryEquityOptionsTransferOfPreferredStockToPermanentEquity
3703000 usd
CY2024Q1 rnac Transfer Of Temporary Equity To Permanent Equity
TransferOfTemporaryEquityToPermanentEquity
375751000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
154000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2877000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1431000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-56824000 usd
CY2024Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2024Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2024Q1 rnac Temporary Equity Options Carrying Amount Attributable To Parent
TemporaryEquityOptionsCarryingAmountAttributableToParent
0 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-116800000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 usd
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
120000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
219000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1591000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
14000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
13836000 usd
CY2024Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2024Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2024Q2 rnac Temporary Equity Options Carrying Amount Attributable To Parent
TemporaryEquityOptionsCarryingAmountAttributableToParent
0 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
93828000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
149000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2276000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-22000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
11000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-21663000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
74579000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2283000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-27000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-11387000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
65448000 usd
us-gaap Net Income Loss
NetIncomeLoss
-42988000 usd
us-gaap Net Income Loss
NetIncomeLoss
-33050000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
379000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
382000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
79000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1113000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
842000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3022000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
6059000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
0 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
533000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2866000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2262000 usd
rnac Fair Value Adjustment Of Contingent Value Right Liability
FairValueAdjustmentOfContingentValueRightLiability
36800000 usd
rnac Fair Value Adjustment Of Contingent Value Right Liability
FairValueAdjustmentOfContingentValueRightLiability
0 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-6890000 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
26169000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1211000 usd
rnac Increase Decrease In Contract With Customer Asset Allowance For Credit Loss Current
IncreaseDecreaseInContractWithCustomerAssetAllowanceForCreditLossCurrent
491000 usd
rnac Increase Decrease In Contract With Customer Asset Allowance For Credit Loss Current
IncreaseDecreaseInContractWithCustomerAssetAllowanceForCreditLossCurrent
-2107000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2848000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-815000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-290000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-49000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5849000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
8504000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-8496000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3673000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30363000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18660000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
0 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
28254000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2189000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
142000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2189000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
28112000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2586000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2877000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
40000000 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
274000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
149000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
43151000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2437000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-49000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10608000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6966000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78288000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108038000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
88896000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
115004000 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
1242000 usd
rnac Stock Based Compensation Expense Incurred But Not Yet Paid
StockBasedCompensationExpenseIncurredButNotYetPaid
0 usd
rnac Stock Based Compensation Expense Incurred But Not Yet Paid
StockBasedCompensationExpenseIncurredButNotYetPaid
1500000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2879000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
48000 usd
rnac Equity Offering Costs Incurred But Not Yet Paid
EquityOfferingCostsIncurredButNotYetPaid
219000 usd
rnac Equity Offering Costs Incurred But Not Yet Paid
EquityOfferingCostsIncurredButNotYetPaid
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2024Q2 rnac Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Debt Securities Available For Sale
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale
88900000 usd
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1700000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-657600000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
13836000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-11387000 usd
us-gaap Net Income Loss
NetIncomeLoss
-42988000 usd
us-gaap Net Income Loss
NetIncomeLoss
-33050000 usd
CY2024Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
4208000 usd
CY2024Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
4208000 usd
CY2023Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
CY2023Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
0 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
0 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
0 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
9628000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
9628000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11387000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-11387000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-42988000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-42988000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-33050000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-33050000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16723479 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5114747 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11068749 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5113213 shares
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1067664 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17791143 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5114747 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11068749 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5113213 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.58
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.88
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.46
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.88
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.46
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7260062 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1794533 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8863868 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1794533 shares
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0 usd
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
87227000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
112027000 usd
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1600000 usd
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1669000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1377000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
88896000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
115004000 usd
CY2023Q4 rnac Settlement Of Derivative Liability Shares
SettlementOfDerivativeLiabilityShares
148710.488 shares
CY2023Q4 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
28307000 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Settlements
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements
35197000 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
-6890000 usd
CY2024Q2 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
0 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12701000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7841000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6029000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5728000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6672000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2113000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
200000 usd
CY2024Q2 us-gaap Depreciation
Depreciation
200000 usd
us-gaap Depreciation
Depreciation
400000 usd
us-gaap Depreciation
Depreciation
400000 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1402000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4390000 usd
CY2024Q2 rnac Accrued Patent Fees Current
AccruedPatentFeesCurrent
689000 usd
CY2023Q4 rnac Accrued Patent Fees Current
AccruedPatentFeesCurrent
472000 usd
CY2024Q2 rnac Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
3467000 usd
CY2023Q4 rnac Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
4896000 usd
CY2024Q2 rnac Accrued Audit Fees Current
AccruedAuditFeesCurrent
1871000 usd
CY2023Q4 rnac Accrued Audit Fees Current
AccruedAuditFeesCurrent
4331000 usd
CY2024Q2 rnac Accrued Property Plant And Equipment Current
AccruedPropertyPlantAndEquipmentCurrent
2877000 usd
CY2023Q4 rnac Accrued Property Plant And Equipment Current
AccruedPropertyPlantAndEquipmentCurrent
128000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
309000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
516000 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10615000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14733000 usd
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
956000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
696000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
1731000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
1392000 usd
CY2024Q2 us-gaap Variable Lease Cost
VariableLeaseCost
352000 usd
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
270000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
749000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
412000 usd
CY2024Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1000 usd
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
4000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
5000 usd
CY2024Q2 us-gaap Sublease Income
SubleaseIncome
250000 usd
CY2023Q2 us-gaap Sublease Income
SubleaseIncome
251000 usd
us-gaap Sublease Income
SubleaseIncome
760000 usd
us-gaap Sublease Income
SubleaseIncome
506000 usd
CY2024Q2 us-gaap Lease Cost
LeaseCost
1059000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
717000 usd
us-gaap Lease Cost
LeaseCost
1724000 usd
us-gaap Lease Cost
LeaseCost
1303000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1239000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4350000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4471000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4276000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2243000 usd
CY2024Q2 rnac Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
3409000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
19988000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5121000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
14867000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1604000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1319000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y10M24D
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y10M24D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.115
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.097
CY2023Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
548375 shares
CY2023Q4 rnac Settlement Of Derivative Liability Shares
SettlementOfDerivativeLiabilityShares
148710.488 shares
CY2023Q4 rnac Settlement Of Derivative Liability Shares
SettlementOfDerivativeLiabilityShares
49570.162 shares
CY2024Q1 rnac Settlement Of Derivative Liability Shares
SettlementOfDerivativeLiabilityShares
49570.163 shares
CY2024Q1 rnac Number Of Business Days
NumberOfBusinessDays
8 business_day
CY2024Q2 rnac Convertible Preferred Stock Shares That Did Not Automatically Convert
ConvertiblePreferredStockSharesThatDidNotAutomaticallyConvert
166341.592 shares
CY2024Q2 us-gaap Preferred Stock Convertible Shares Issuable
PreferredStockConvertibleSharesIssuable
5544719 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1040813 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
45.98
rnac Stock Issued During Period Shares Warrants Exercised
StockIssuedDuringPeriodSharesWarrantsExercised
65681 shares
rnac Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercises
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercises
43.80
CY2024Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
975132 shares
CY2024Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
46.12
CY2024Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
12794858 shares
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1591000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3783000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3022000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6059000 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
17.40
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
30.51
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
16.05
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
26.89
CY2024Q1 us-gaap Preferred Stock Convertible Conversion Ratio
PreferredStockConvertibleConversionRatio
33.333
CY2024Q1 us-gaap Preferred Stock Convertible Conversion Ratio
PreferredStockConvertibleConversionRatio
33.333
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0 usd
CY2023Q4 rnac Contract With Customer Liability Deferred Revenue
ContractWithCustomerLiabilityDeferredRevenue
5849000 usd
rnac Contract With Customer Liability Deferred Revenue Increase From Cash Receipts
ContractWithCustomerLiabilityDeferredRevenueIncreaseFromCashReceipts
0 usd
rnac Contract With Customer Liability Deferred Revenue Revenue Recognized
ContractWithCustomerLiabilityDeferredRevenueRevenueRecognized
-5849000 usd
CY2024Q2 rnac Contract With Customer Liability Deferred Revenue
ContractWithCustomerLiabilityDeferredRevenue
0 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
5849000 usd
rnac Contract With Customer Liability Increase From Cash Receipts
ContractWithCustomerLiabilityIncreaseFromCashReceipts
0 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-5849000 usd
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0 usd
rnac Defined Contribution Plan Employers Matching Contribution Vesting Period
DefinedContributionPlanEmployersMatchingContributionVestingPeriod
P2Y
CY2024Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000 usd
CY2023Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000 usd
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000 usd
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
200000 usd
us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.89
CY2023 us-gaap Restructuring Charges
RestructuringCharges
6400000 usd
CY2023 us-gaap Payments For Restructuring
PaymentsForRestructuring
2500000 usd
us-gaap Restructuring Charges
RestructuringCharges
800000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
4500000 usd
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
3896000 usd
us-gaap Restructuring Charges
RestructuringCharges
805000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
4527000 usd
CY2024Q2 us-gaap Restructuring Reserve
RestructuringReserve
174000 usd
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001453687-24-000102-index-headers.html Edgar Link pending
0001453687-24-000102-index.html Edgar Link pending
0001453687-24-000102.txt Edgar Link pending
0001453687-24-000102-xbrl.zip Edgar Link pending
exhibit311_6302024.htm Edgar Link pending
exhibit312_6302024.htm Edgar Link pending
exhibit321_6302024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rnac-20240630.htm Edgar Link pending
rnac-20240630.xsd Edgar Link pending
Show.js Edgar Link pending
rnac-20240630_def.xml Edgar Link unprocessable
rnac-20240630_lab.xml Edgar Link unprocessable
rnac-20240630_htm.xml Edgar Link completed
rnac-20240630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
rnac-20240630_pre.xml Edgar Link unprocessable